// App-Quantinova.ai

438 : Abnormal Metaphase Cytogenetics Adds to Currently Known Risk-Factors for Venous Thromboembolism in Multiple Myeloma: Derivation of the PRISM score

Researchers

Presenter

  • Rajshekhar Chakraborty

Principal Investigators

  • Lisa Rybicki

  • Jason Valent

  • Alex V. Mejia Garcia

  • Beth M. Faiman

  • Jack Khouri

  • Nathaniel Rosko

  • Christy J. Samaras

  • Matt Kalaycio

  • Faiz Anwer

  • Alok A Khorana

Medical Centers

  • Department of Urology, Columbia University Medical Center, New York, NY

  • Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

  • Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved